Beyond live microorganisms, inanimate microorganisms and their components can also confer a health benefit on the host. A panel of experts under the auspices of the International Scientific Association for Probiotics and Prebiotics (ISAPP) updates the definition and scope of postbiotics.
The low FODMAP diet can pose challenges for people with IBS. What can be done to minimize some of those challenges in clinical practice?
10 May 2021by Andreu Prados
The low FODMAP diet has been shown to be effective in managing the symptoms of IBS as second-line dietary advice when healthy eating approaches have failed to reduce symptoms. However, this eliminative diet is not without its challenges, which can be overcome by following the advice found below.
Analysing the molecular and biochemical mechanisms disturbing the complex network of communication is key to our understanding of the pathophysiology of the functional GI disorders. Together with ESNM we have prepared an exciting webinar series under the topic: Microbiota and Gut-Brain Connection: A new Frontier in Neurogastroenterology. This free resource is a great opportunity to hear leading worldwide experts presenting the most recent findings on this topic.
The role of probiotics on respiratory and gastrointestinal tract infections in healthy people: what science says today?
29 Mar 2021by Andreu Prados
The role of gut microbiota in shaping immune responses has led scientists to explore the modulation of the immune system as a mechanism underlying the health benefits of probiotics. A new systematic review and meta-analysis of 9 randomized clinical trials suggest probiotics may reduce the incidence of respiratory and gastrointestinal tract infections in generally healthy children and adults.
Does functional abdominal pain have an organic explanation? Gut-localized immune responses offer new clues for patients with functional gastrointestinal disorders
8 Mar 2021by Rene van den Wijngaard
Abdominal pain affects a huge amount of people nowadays, though its underlying mechanisms are not always understood. New findings in mice and humans reveal that localized immune responses against harmless foods might be involved in persistent “functional” abdominal pain.
Is it time to consider next-generation beneficial microbes for tackling obesity?
15 Feb 2021by Andreu Prados
Is it time to consider next-generation beneficial microbes for tackling obesity? APC Microbiome Ireland researchers identify Bifidobacterium longum APC1472 as a promising candidate
2020 at a glance: A year of important scientific progress in gut microbiome research
1 Feb 2021by GMFH Editing Team
In 2020, we saw important scientific advances in our understanding of how the gut microbiome contributes to human health beyond the gastrointestinal milieu. Discover the year’s breakthroughs in this “2020 Year at a glance” report.
Should dietary guidelines advise consumers to deliberately include safe microorganisms in their diets?
18 Jan 2021by Andreu Prados
While for almost all of human evolution our food and water have contained large numbers of microorganisms, the industrialized human diet contains low microbial numbers. So are we ready to recommend a specific daily intake of microbes?
The pharmacist inside us: what are the implications of drug-gut microbiome interactions in the clinical setting?
4 Jan 2021by GMFH Editing Team
Beyond antibiotics, a wide range of commonly used non-antibiotic drugs can affect the gut microbiome. In addition, the gut microbiome can also influence an individual’s response to drugs by affecting their efficacy and safety. What are the implications of the bidirectional interaction between non-antibiotic drugs and the gut microbiome in the clinical setting?
What major scientific breakthroughs have been made in gut microbiome science in 2020?
28 Dec 2020by Andreu Prados
Although the COVID-19 pandemic has shifted the focus of research for scientists worldwide, major breakthroughs in gut microbiome science have been made in 2020. In this last post of the year, we bring you articles from our blog that cover the major advances in the gut microbiome in 2020, from bench to bedside.
